Cargando…

Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers

INTRODUCTION: The response is poorly understood to the third dose in patients with cancer who failed the standard dose of inactivated SARS-CoV-2 vaccines (CoronaVac). We aim to assess the immune response to the third dose and identify whether vitamin D deficiency is associated with serial serologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yifei, Zhu, Pengfei, Zhong, Guanqing, Wang, Dao, Cao, Lu, Bai, Shenrui, Wang, Youlong, Zhang, Ao, Wang, Xinjia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373038/ https://www.ncbi.nlm.nih.gov/pubmed/35966864 http://dx.doi.org/10.3389/fmed.2022.898606

Ejemplares similares

Parent Acceptance toward Inactivated COVID-19 Vaccination in Children with Acute Lymphoblastic Leukemia: The Power of Oncologist and Alliance
por: Ma, Yifei, et al.
Publicado: (2022)

Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination
por: Ma, Yifei, et al.
Publicado: (2023)

Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
por: Ma, Yifei, et al.
Publicado: (2021)

Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
por: Ma, Yifei, et al.
Publicado: (2023)

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human
por: Zhang, Yuwei, et al.
Publicado: (2022)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023)

Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis
por: Ma, Yifei, et al.
Publicado: (2023)

Standards, an innovation booster?
por: DE CASANOVE, Alice
Publicado: (2014)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Parental Attachment and Adolescent Moral Reaction Modes: The Serial Mediating Model of the Teacher–Student Relationship and Deviant Peer Affiliation
por: Liu, Changlin, et al.
Publicado: (2022)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Measurement and Compensation of Second and Third Order Resonances at the CERN PS Booster
por: Urschütz, Peter
Publicado: (2004)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review
por: Al Hajji, Youssra, et al.
Publicado: (2022)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

E-serials: publishers, libraries, users, and standards
por: Jones, Wayne
Publicado: (1998)

Serial Cardiovascular Magnetic Resonance Studies Prior to and After mRNA-Based COVID-19 Booster Vaccination to Assess Booster-Associated Cardiac Effects
por: Meier, Claudia, et al.
Publicado: (2022)

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
por: Tangsathapornpong, Auchara, et al.
Publicado: (2023)

Role of vitamins and minerals as immunity boosters in COVID-19
por: Kumar, Puneet, et al.
Publicado: (2021)

Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
por: Li, Haolong, et al.
Publicado: (2023)

Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
por: Xiao, Chanchan, et al.
Publicado: (2022)

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
por: Nanthapisal, Sira, et al.
Publicado: (2022)

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults
por: Zhang, Yuntao, et al.
Publicado: (2022)

IEEE standard microcontroller system serial control bus /
Publicado: (1991)

A standard descriptor for fixed-target serial crystallography
por: Owen, Robin L., et al.
Publicado: (2023)

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
por: Ranzani, Otavio T., et al.
Publicado: (2022)

Immunostimulating Effect of Inactivated Parapoxvirus Ovis on the Serological Response to Equine Influenza Booster Vaccination
por: Carnet, Flora, et al.
Publicado: (2022)

Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China
por: Sun, Yufang, et al.
Publicado: (2022)

Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy
por: Dick, Aharon, et al.
Publicado: (2022)

Beating the standard quantum limit under ambient conditions with solid-state spins
por: Xie, Tianyu, et al.
Publicado: (2021)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
por: Dib, Martín, et al.
Publicado: (2022)

Handbook of serial communications interfaces: a comprehensive compendium of serial digital input/output (I/O) standards
por: Frenzel, Louis
Publicado: (2015)

Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
por: Liu, Yongmei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3lddufsmkunaropmjurstha4lg